SNES
Senestech Inc
NASDAQ · Pharmaceuticals
$1.87
+0.09 (+5.06%)
Income Statement
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.54M | 1.47M | 1.59M |
| Net Income | 441.7K | 533.2K | 527.1K |
| EPS | — | — | — |
| Profit Margin | 28.7% | 36.3% | 33.2% |
| Rev Growth | -7.1% | +11.3% | -5.2% |
Balance Sheet
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Total Debt | 2.00M | 2.27M | 1.95M |
| Total Equity | 4.51M | 4.98M | 4.41M |
| D/E Ratio | 0.44 | 0.46 | 0.44 |
Cash Flow
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| EBITDA | 725.7K | 838.1K | 900.8K |
| Free Cash Flow | 442.9K | 521.2K | 519.7K |